Video Experimental Relacionado
Updated: Aug 14, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
El aerosol de triamcinolona. también conocido como triamcinolona. Tratamiento de los pacientes asmáticos
JAMA
|November 14, 1977
Resumen
El aerosol de triamcinolona acetonida manejó eficazmente el asma en pacientes con hipersensibilidad a la aspirina, reduciendo las necesidades de corticosteroides. La función pulmonar mejoró, sin efectos secundarios significativos observados durante el ensayo.
Área de la Ciencia:
- Pulmonología Pulmonología.
- Alergia e Inmunología.
- Farmacología Farmacología.
Sus antecedentes:
- El manejo del asma en pacientes con hipersensibilidad a la aspirina presenta desafíos.
- La dependencia sistémica de corticosteroides es común en casos graves.
- Las terapias anteriores como el cromolyn sodio pueden ser ineficaces.
Objetivo del estudio:
- Para evaluar la eficacia del aerosol de triamcinolona acetonida.
- Para evaluar su papel en el manejo del asma en pacientes hipersensibles a la aspirina.
- Para determinar su impacto en los requisitos de corticosteroides y la función pulmonar.
Principales métodos:
- Se llevó a cabo un ensayo clínico de un año.
- Seis pacientes con hipersensibilidad a la aspirina y asma participaron.
- El aerosol de triamcinolona acetonida fue administrado.
- Se monitorearon las necesidades de corticosteroides y la función pulmonar (FEV).
Principales resultados:
- Se observó una reducción significativa en las necesidades sistémicas de corticosteroides.
- Dos pacientes interrumpieron por completo el tratamiento con prednisona oral.
- La función pulmonar, incluido el volumen expiratorio forzado (FEV), se mantuvo estable o mejoró.
- No se informaron efectos adversos significativos relacionados con la triamcinolona.
Conclusiones:
- El aerosol de triamcinolona acetonida es una opción de tratamiento eficaz para el asma.
- Puede reducir la dependencia de los corticosteroides sistémicos en pacientes hipersensibles a la aspirina.
- El tratamiento demuestra un perfil de seguridad favorable y mantiene la función pulmonar.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...